Sign in
SLGC Stock Price, Chart, Stats & News
SomaLogic, Inc.
Save
396.23M
Market cap
–
Current P/E
–
Forward P/E
SLGC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 55.60% |
Operating margin | -179.96% |
Pretax margin | -112.50% |
Net margin | -111.77% |
Effective tax rate | 0.65% |
ROA | -16.86% |
ROE | -18.59% |
D/E | 0.00x |
Interest coverage ratio | – |
SLGC valuation
P/E | – |
P/S | 4.06x |
P/B | 0.69x |
P/CF | -3.84x |
P/FCF | -3.74x |
P/OCF | -3.84x |
PEG | -0.04x |
EV multiple | -4.64x |
About
SomaLogic, Inc. is a U. S.-based enterprise specializing in the identification of protein biomarkers and the development of clinical diagnostic solutions. A core aspect of its technology involves the creation of slow off-rate modified aptamers (SOMAmers) – unique nucleic acid-based reagents meticulously designed to specifically bind with their target proteins.
Similar securities
Based on sector and market capitalization
Report issue